Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Matthew Biegler is an analyst at Oppenheimer. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/07/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/08/2024 | IDYA | Buy Now | IDEAYA Biosciences | $39.67 | 51.25% | $53 → $60 | Maintains | Outperform | Get Alert |
| 07/08/2024 | BPMC | Buy Now | Blueprint Medicines | $116.32 | 7.46% | $114 → $125 | Maintains | Outperform | Get Alert |
| 07/03/2024 | TYRA | Buy Now | Tyra Biosciences | $17.72 | 58.01% | $28 → $28 | Reiterates | Outperform → Outperform | Get Alert |
| 07/02/2024 | RNAC | Buy Now | Cartesian Therapeutics | $16.60 | — | — | Downgrade | Outperform → Peer Perform | Get Alert |
| 06/24/2024 | RNAC | Buy Now | Cartesian Therapeutics | $16.60 | 201.2% | $50 → $50 | Reiterates | Outperform → Outperform | Get Alert |
| 06/18/2024 | ZNTL | Buy Now | Zentalis Pharma | $4.18 | 498.09% | $50 → $25 | Maintains | Outperform | Get Alert |
| 06/14/2024 | RNAC | Buy Now | Cartesian Therapeutics | $16.60 | 201.2% | $50 → $50 | Maintains | Outperform | Get Alert |
| 06/04/2024 | RNAC | Buy Now | Cartesian Therapeutics | $16.60 | 201.2% | → $50 | Initiates | → Outperform | Get Alert |
| 05/14/2024 | FULC | Buy Now | Fulcrum Therapeutics | $6.05 | 131.4% | $16 → $14 | Maintains | Outperform | Get Alert |
| 05/13/2024 | VOR | Buy Now | Vor Biopharma | $0.91 | 1003.63% | $15 → $10 | Reiterates | Outperform → Outperform | Get Alert |
| 05/13/2024 | TYRA | Buy Now | Tyra Biosciences | $17.72 | 58.01% | $25 → $28 | Reiterates | Outperform → Outperform | Get Alert |
| 05/06/2024 | RLAY | Buy Now | Relay Therapeutics | $6.48 | 285.8% | $33 → $25 | Reiterates | Outperform → Outperform | Get Alert |
| 04/01/2024 | ELTX | Buy Now | Elicio Therapeutics | $3.52 | — | — | Reiterates | Perform → Perform | Get Alert |
| 03/21/2024 | VOR | Buy Now | Vor Biopharma | $0.91 | 1555.45% | $17 → $15 | Reiterates | Outperform → Outperform | Get Alert |
| 03/19/2024 | ALPN | Buy Now | Alpine Immune Sciences | — | — | $33 → $44 | Reiterates | Outperform → Outperform | Get Alert |
| 03/12/2024 | ORIC | Buy Now | ORIC Pharmaceuticals | $8.50 | 100% | $14 → $17 | Maintains | Outperform | Get Alert |
| 03/12/2024 | OLMA | Buy Now | Olema Pharmaceuticals | $11.02 | 90.56% | $21 → $21 | Reiterates | Outperform → Outperform | Get Alert |
| 02/28/2024 | ARVN | Buy Now | Arvinas | $25.68 | 211.53% | $95 → $80 | Reiterates | Outperform → Outperform | Get Alert |
| 02/27/2024 | FATE | Buy Now | Fate Therapeutics | $3.10 | — | — | Reiterates | Perform → Perform | Get Alert |
| 02/27/2024 | DAWN | Buy Now | Day One Biopharmaceutical | $14.80 | — | — | Reiterates | Perform → Perform | Get Alert |
| 10/27/2023 | BPMC | Buy Now | Blueprint Medicines | $116.32 | -26.93% | → $85 | Upgrade | Perform → Outperform | Get Alert |
| 09/06/2023 | OLMA | Buy Now | Olema Pharmaceuticals | $11.02 | 90.56% | → $21 | Reiterates | Outperform → Outperform | Get Alert |
| 08/22/2023 | FULC | Buy Now | Fulcrum Therapeutics | $6.05 | 164.46% | → $16 | Reiterates | Outperform → Outperform | Get Alert |
| 08/14/2023 | MDNA | Buy Now | Medicenna Therapeutics | — | — | $8 → $3 | Maintains | Outperform | Get Alert |
| 08/11/2023 | APTO | Buy Now | Aptose Biosciences | $0.79 | 1789.88% | $50 → $15 | Maintains | Outperform | Get Alert |
| 08/11/2023 | IDYA | Buy Now | IDEAYA Biosciences | $39.67 | -11.77% | $30 → $35 | Maintains | Outperform | Get Alert |
| 08/09/2023 | RLAY | Buy Now | Relay Therapeutics | $6.48 | 409.26% | → $33 | Reiterates | Outperform → Outperform | Get Alert |
| 07/21/2023 | OLMA | Buy Now | Olema Pharmaceuticals | $11.02 | 90.56% | → $21 | Initiates | → Outperform | Get Alert |
| 06/12/2023 | APTO | Buy Now | Aptose Biosciences | $0.79 | 6199.61% | $9 → $50 | Maintains | Outperform | Get Alert |
| 06/02/2023 | AMAM | Buy Now | Ambrx Biopharma | — | — | → $30 | Initiates | → Outperform | Get Alert |
| 06/02/2023 | ACRV | Buy Now | Acrivon Therapeutics | $7.08 | 253.11% | → $25 | Initiates | → Outperform | Get Alert |
| 05/26/2023 | ZNTL | Buy Now | Zentalis Pharma | $4.18 | 1096.17% | → $50 | Reiterates | Outperform → Outperform | Get Alert |
| 05/16/2023 | FULC | Buy Now | Fulcrum Therapeutics | $6.05 | 164.46% | $20 → $16 | Maintains | Outperform | Get Alert |
| 05/15/2023 | VOR | Buy Now | Vor Biopharma | $0.91 | 1886.54% | → $18 | Reiterates | Outperform → Outperform | Get Alert |
| 05/11/2023 | ZNTL | Buy Now | Zentalis Pharma | $4.18 | 1096.17% | → $50 | Reiterates | Outperform → Outperform | Get Alert |
| 05/09/2023 | APTO | Buy Now | Aptose Biosciences | $0.79 | 1033.93% | → $135 | Reiterates | → Outperform | Get Alert |
| 05/08/2023 | TYRA | Buy Now | Tyra Biosciences | $17.72 | 41.08% | → $25 | Reiterates | → Outperform | Get Alert |
| 04/18/2023 | RLAY | Buy Now | Relay Therapeutics | $6.48 | 409.26% | → $33 | Maintains | Outperform | Get Alert |
| 03/24/2023 | VOR | Buy Now | Vor Biopharma | $0.91 | 1886.54% | → $18 | Reiterates | → Outperform | Get Alert |
| 03/16/2023 | ORIC | Buy Now | ORIC Pharmaceuticals | $8.50 | 64.71% | → $14 | Upgrade | Perform → Outperform | Get Alert |
| 02/27/2023 | FULC | Buy Now | Fulcrum Therapeutics | $6.05 | 230.58% | $26 → $20 | Maintains | Outperform | Get Alert |
| 02/03/2023 | DAWN | Buy Now | Day One Biopharmaceutical | $14.80 | — | — | Initiates | → Perform | Get Alert |
| 02/03/2023 | TYRA | Buy Now | Tyra Biosciences | $17.72 | -4.06% | → $17 | Initiates | → Outperform | Get Alert |
| 02/03/2023 | RLAY | Buy Now | Relay Therapeutics | $6.48 | 409.26% | → $33 | Initiates | → Outperform | Get Alert |
| 12/22/2022 | NKTX | Buy Now | Nkarta | $5.30 | — | — | Downgrade | Outperform → Perform | Get Alert |
| 12/22/2022 | FATE | Buy Now | Fate Therapeutics | $3.10 | — | — | Downgrade | Outperform → Perform | Get Alert |
| 12/22/2022 | CELU | Buy Now | Celularity | $3.10 | — | — | Downgrade | Outperform → Perform | Get Alert |
| 11/30/2022 | PRTG | Buy Now | Portage Biotech | $0.16 | 10868.92% | $26 → $18 | Maintains | Outperform | Get Alert |
| 11/14/2022 | VOR | Buy Now | Vor Biopharma | $0.91 | 1886.54% | $27 → $18 | Maintains | Outperform | Get Alert |
| 11/10/2022 | ZNTL | Buy Now | Zentalis Pharma | $4.18 | 1096.17% | $80 → $50 | Maintains | Outperform | Get Alert |
| 11/10/2022 | NKTX | Buy Now | Nkarta | $5.30 | 579.25% | $50 → $36 | Maintains | Outperform | Get Alert |
| 11/02/2022 | BPMC | Buy Now | Blueprint Medicines | $116.32 | — | — | Downgrade | Outperform → Perform | Get Alert |
| 09/06/2022 | BPMC | Buy Now | Blueprint Medicines | $116.32 | -22.63% | $80 → $90 | Maintains | Outperform | Get Alert |
| 08/16/2022 | IDYA | Buy Now | IDEAYA Biosciences | $39.67 | -49.58% | $25 → $20 | Maintains | Outperform | Get Alert |
| 07/08/2022 | BPMC | Buy Now | Blueprint Medicines | $116.32 | -31.22% | → $80 | Initiates | → Outperform | Get Alert |
| 06/23/2022 | MDNA | Buy Now | Medicenna Therapeutics | — | — | $12 → $10 | Maintains | Outperform | Get Alert |
| 04/12/2022 | ZNTL | Buy Now | Zentalis Pharma | $4.18 | 1933.49% | $100 → $85 | Maintains | Outperform | Get Alert |
| 03/08/2022 | FULC | Buy Now | Fulcrum Therapeutics | $6.05 | 445.45% | → $33 | Initiates | → Outperform | Get Alert |
| 02/22/2022 | FIXX | Buy Now | Homology Medicines | — | — | — | Downgrade | Outperform → Perform | Get Alert |
| 01/28/2022 | CELU | Buy Now | Celularity | $3.10 | 190.32% | → $90 | Initiates | → Outperform | Get Alert |
| 01/21/2022 | TPTX | Buy Now | Turning Point | — | — | $115 → $105 | Maintains | Outperform | Get Alert |
| 12/02/2021 | VOR | Buy Now | Vor Biopharma | $0.91 | 3210.89% | — | Initiates | → Outperform | Get Alert |
| 03/16/2020 | FIXX | Buy Now | Homology Medicines | — | — | → $576 | Upgrade | Perform → Outperform | Get Alert |
